>> THE COUNTDOWN IS ON. EVERYTHING YOU NEED TO GET THE EDGE AT THE END OF THE MARKET DAY. THIS IS THE CLOSE.>> THE FIGHT OVER ACCESS TO CAPITAL. I'M ROMAINE BOSTICK. >> KICKING OFF TO THE CLOSING BELL, MARKETS STAGING THE REBOUND AFTER THE TREASURY ANNOUNCED PLANS TO BUY BACK LOWER DATED BONDS.YIELDS HIT ALL-TIME HIGHS. THE S&P INCHING HIGHER BY 0.3%, CHIPS ARE THE BIGGEST LOSERS DOWN BY 2%. WE HAVE THE DOLLAR HITTING ITS LOWEST IN THREE MONTHS.>> SCOTT BESSENT NINE MONTHS AGO FAMOUSLY SAID IT IS HIS JOB TO ...

This is Guru Focus Market Today, your afternoon market brief for Wednesday, August 19th. Here's where things stand. Major US stock indices rebounded sharply, snapping a 3-day losing streak as the Dow, S&P 500, and Nasdaq all posted gains.The rally was driven by a recovery in bond markets and strong performance from MADNA which surged on positive clinical trial results. The rebound followed a period of volatility linked to rising yields and global bond market declines. Turning now to Madna and Merc.The two c ...

Moderna co-founder Robert Langer is a billionaire once again, according to Forbes’ estimates, as shares in the biotech giant doubled in value on Wednesday following positive results from a late-stage trial of a cancer vaccine. https://t.co/SPaMNkjkKa ...

Moderna ($MRNA) is the biotech behind one of the fastest vaccine developments in history, home to an mRNA platform spanning COVID, RSV, flu, and individualized cancer treatment.Verify the address on @tokens: https://t.co/aMUWruvyLK ...

BREAKING: $MRNA from Moderna is live on Solana via @sunrise, issued by @Backpack SecuritiesModerna announced the first ever positive Phase 3 results for a personalized cancer vaccinehttps://t.co/vkyVEQeuYpNone (@None):Sunrise has listed $MRNA on @Solana.Today, Moderna and Merck reported the first positive Phase 3 results for an mRNA cancer therapy.Issued by @Backpack Securities, a tokenized Moderna share now trades on Solana, 24/7. https://t.co/uqGE6y1HXH ...

Market Overview & Macro Trends - S&P 500 rose 17 points or 0.2%, and the Dow gained over 100 points or 0.2%[7] - Tech sector declined by nearly 2% or more, while consumer staples, energy, and materials increased by 0.2% to 0.3%[8][9] - Long-term bond yields dropped significantly, with the 20-year yield falling 11 basis points and the 30-year yield falling 10 basis points[26] Corporate Performance & Stock Movements - Moderna shares surged 30% on the day and 491% year-to-date, backed by 13% of the float short, after a melanoma vaccine trial showed positive results[9][11][12] - Estee Lauder shares jumped 16%, marking its best day since November 2011, reporting fourth-quarter revenue of $3.6 billion and organic sales growth accelerating to 5%[14][15] - Twist Bioscience shares rose 22% to a more than five-year high after being chosen as an independent evaluator for Anthropic[16] - TJX Group shares fell about 4% as the MA Max segment's second-quarter comparable sales missed estimates[18][19] - Viking Holdings shares dropped about 8% amid investor concerns regarding low water levels in the Danube and Rhine rivers, despite booking 53% of its 2027 capacity[22][23] - White Fiber priced a private placement of $270 million in senior notes to build out AI infrastructure, with its market cap standing at about $1 billion and shares falling 21%[24][25]

Moderna co-founder Robert Langer is a billionaire once again, according to Forbes’ estimates, as shares in the biotech giant doubled in value on Wednesday following positive results from a late-stage trial of a cancer vaccine.Read more: https://t.co/gEPzuLJKNUPhoto: Taylor Hill via Getty Images ...

>> LIVE FROM WASHINGTON DC, THIS IS "BALANCE OF POWER" WITH JOE MATHIEU AND KAILEY LEINZ. KAILEY: THE TRUMP ADMINISTRATION IS WATCHING THE BOND MARKET, CANADA AND TECH. WELCOME TO "BALANCE OF POWER." THE PRESIDENT PUNTING ON NEW CANADIAN TARIFFS THAT WERE SET TO GO INTO EFFECT TODAY AND INSTEAD SHIFT HIS FOCUS TO A MEETING AT THE WHITE HOUSE THIS AFTERNOON WITH THE LEADERS OF BIG TECH AND CRYPTO COMPANIES.WE GET THE LATEST FROM THE WHITE HOUSE FROM BLOOMBERG'S TYLER KENDALL, AND TALK ABOUT THE CEOS WHO WERE ...

$MRNA is onchain & trending with $28.3M traded in 24h.Moderna announced positive Phase 3 results today for its mRNA melanoma therapy.$MRNA is accessible as perpetual markets or RWAs on Trust Wallet. https://t.co/kbd6JzI1t1 ...

Moderna shares more than doubled after its personalized cancer vaccine cleared a late-stage melanoma trialThe shot, intismeran, is tailored to mutations in each patient's tumor and was tested alongside Merck's Keytruda. Patients on the combination went longer without the cancer returning or spreading than those on Keytruda alone.The treatment is not approved and @moderna_tx released initial results only. $MRNA traded at $158.29 against a previous close of $62.96, with short sellers facing about $5B in losse ...